Examining the etiological factors resulting in retinal detachment following prophylactic vitrectomy in the context of acute retinal necrosis syndrome.


Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
13 Jun 2024
Historique:
received: 11 01 2024
accepted: 06 06 2024
medline: 14 6 2024
pubmed: 14 6 2024
entrez: 13 6 2024
Statut: epublish

Résumé

The aim of this study is to elucidate the factors contributing to the occurrence of retinal detachment (RD) following prophylactic vitrectomy in cases of acute retinal necrosis (ARN) syndrome. A retrospective examination was undertaken, encompassing the medical records of patients diagnosed with ARN who underwent prophylactic vitreous intervention at the Ophthalmology Department of Wuhan University Renmin Hospital East Campus between October 2019 and September 2023. Subsequently, patients who manifested RD in the postoperative period were identified, and a comprehensive analysis was conducted to ascertain the factors underlying the occurrence of RD post-surgery. This study comprised 14 cases (involving 14 eyes) of patients diagnosed with ARN who underwent prophylactic vitreous intervention. The findings revealed that 4 patients experienced postoperative RD, resulting in an incidence rate of 28.57%. Notably, among these cases, 3 cases of RD manifested in the presence of silicone oil, while 1 case occurred subsequent to the removal of silicone oil. All 4 cases of RD exhibited varied degrees of proliferative vitreoretinopathy. Following the occurrence of RD, all patients underwent a secondary vitreous intervention coupled with silicone oil tamponade, leading to successful reattachment of the retina. However, despite these interventions, there was no significant enhancement observed in postoperative visual outcomes when compared to preoperative levels. RD following prophylactic vitrectomy in cases of ARN is not an infrequent occurrence and is primarily linked to the postoperative onset of proliferative vitreoretinopathy.

Identifiants

pubmed: 38872161
doi: 10.1186/s12886-024-03518-2
pii: 10.1186/s12886-024-03518-2
doi:

Substances chimiques

Silicone Oils 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

254

Informations de copyright

© 2024. The Author(s).

Références

Ganatra JB, Chandler D, Santos C, Kuppermann B, Margolis TP. Viral causes of the acute retinal necrosis syndrome. Am J Ophthalmol. 2000;129(2):166–72.
doi: 10.1016/S0002-9394(99)00316-5 pubmed: 10682968
Lau CH, Missotten T, Salzmann J, Lightman SL. Acute retinal necrosis features, management, and outcomes. Ophthalmol 2007,114(4): 756–62.
Kawaguchi T, Spencer DB, Mochizuki M. Therapy for acute retinal necrosis. Semin Ophthalmol. 2008;23(4):285–90.
doi: 10.1080/08820530802111192 pubmed: 18584565
Risseeuw S, de Boer JH, Ten DLN, van Leeuwen R. Risk of rhegmatogenous retinal detachment in acute retinal necrosis with and without prophylactic intervention. Am J Ophthalmol. 2019;206:140–8.
doi: 10.1016/j.ajo.2019.05.023 pubmed: 31170391
Luo YH, Duan XC, Chen BH, Tang LS, Guo XJ. Efficacy and necessity of prophylactic vitrectomy for acute retinal necrosis syndrome. Int J Ophthalmol. 2012;5(4):482–7.
pubmed: 22937510 pmcid: 3428546
Ishida T, Sugamoto Y, Sugita S, Mochizuki M. Prophylactic vitrectomy for acute retinal necrosi. Jpn J Ophthalmol. 2009;53(5):486–9.
doi: 10.1007/s10384-009-0698-z pubmed: 19847603
Hillenkamp J, Nolle B, Bruns C, Rautenberg P, Fickenscher H, Roider J. Acute retinal necrosis: clinical features, early vitrectomy, and outcomes. Ophthalmology. 2009;116(10):1971–5.
doi: 10.1016/j.ophtha.2009.03.029 pubmed: 19592111
Zhao XY, Meng LH, Zhang WF, Wang DY, Chen YX. Retinal detachment following acute retinal necrosis and the efficacies of different interventions: a systematic review and Meta-analysis. Retina 2021, 41(5): 965–78.
Holland GN. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. Am J Ophthalmol. 1994;117(5):663–7.
doi: 10.1016/S0002-9394(14)70075-3 pubmed: 8172275
Holland GN, Buhles WJ, Mastre B, Kaplan HJ. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV retinopathy. Study Group. Arch Ophthalmol. 1989;107(12):1759–66.
doi: 10.1001/archopht.1989.01070020841024 pubmed: 2556989
Schoenberger SD, Kim SJ, Thorne JE, Mruthyunjaya P, Yeh S, Bakri SJ, et al. Diagnosis and treatment of acute retinal necrosis: a report by the American academy of ophthalmology. Ophthalmology. 2017;124(3):382–92.
doi: 10.1016/j.ophtha.2016.11.007 pubmed: 28094044
Huang JM, Callanan P, Callanan D, Wang RC. Rate of retinal detachment after early prophylactic vitrectomy for acute retinal necrosis. Ocul Immunol Inflamm. 2018;26(2):204–7.
doi: 10.1080/09273948.2016.1202986 pubmed: 27715365
Iwahashi-Shima C, Azumi A, Ohguro N, Okada AA, Kaburaki T, Goto H, et al. Acute retinal necrosis: factors associated with anatomic and visual outcomes. Jpn J Ophthalmol. 2013;57(1):98–103.
doi: 10.1007/s10384-012-0211-y pubmed: 23117419
Liu S, Wang D, Zhang X. The necessity and optimal time for performing pars plana vitrectomy in acute retinal necrosis patients. Bmc Ophthalmol. 2018;18(1):15–9.
doi: 10.1186/s12886-018-0674-9 pubmed: 29357831 pmcid: 5778764
Fan S, Lin D, Wang Y. Role of prophylactic vitrectomy in acute retinal necrosis in preventing rhegmatogenous retinal detachment: systematic review and meta-analysis. Ocul Immunol Inflamm,2020,1–5.
Wong R, Pavesio CE, Laidlaw DA, Williamson TH, Graham EM, Stanford MR. Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome. Ophthalmology. 2010;117(3):556–60.
doi: 10.1016/j.ophtha.2009.08.003 pubmed: 20031221

Auteurs

Yu-Hong Nie (YH)

Department of Ophthalmology, Renmin Hospital of Wuhan University, No. 99 of Zhangzhidong Road, Wuchang District, Wuhan, 430060, China.

Yu Zhang (Y)

Department of Ophthalmology, Renmin Hospital of Wuhan University, No. 99 of Zhangzhidong Road, Wuchang District, Wuhan, 430060, China.

Zhen Chen (Z)

Department of Ophthalmology, Renmin Hospital of Wuhan University, No. 99 of Zhangzhidong Road, Wuchang District, Wuhan, 430060, China.

Yi-Qiao Xing (YQ)

Department of Ophthalmology, Renmin Hospital of Wuhan University, No. 99 of Zhangzhidong Road, Wuchang District, Wuhan, 430060, China. xing_yiqiao17@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH